Anti-CCR9 antibody [EPR26524-59],Abcam,AB313773

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human, Mouse

Application

IHC-P, WB, Flow Cyt, ICC/IF

Platform ID

BAB681395975

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-CCR9 antibody [EPR26524-59]
Cat. No.AB313773
HostRabbit
IsotypeIgG
ReactivityHuman, Mouse
ApplicationIHC-P, WB, Flow Cyt, ICC/IF
ClonalityMonoclonal
Clone NumberEPR26524-59
Concentration0.494 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Receptor for chemokine SCYA25/TECK. Subsequently transduces a signal by increasing the intracellular calcium ions level.. (Microbial infection) Alternative coreceptor with CD4 for HIV-1 infection. See full target information CCR9

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.